Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.8535
+0.0103 (1.22%)
At close: May 6, 2026, 4:00 PM EDT
0.8335
-0.0200 (-2.34%)
After-hours: May 6, 2026, 4:04 PM EDT

Aprea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
10718181863
Market Cap Growth
21.08%-61.25%2.68%0.11%-72.04%-39.81%
Enterprise Value
-4.94-6.88-3.51-2.73-9.939.66
Last Close Price
0.850.853.294.706.6257.40
PE Ratio
--0.44-1.40-1.19-0.10-1.65
PS Ratio
33.7924.4612.0030.11--
PB Ratio
0.560.560.931.040.681.27
P/TBV Ratio
0.450.450.941.000.431.23
P/FCF Ratio
--0.54-1.33-1.43-0.70-1.66
P/OCF Ratio
--0.54-1.33-1.44-0.70-1.66
EV/Sales Ratio
--24.09-2.33-4.69--
EV/EBITDA Ratio
-0.520.250.180.09-0.26
EV/EBIT Ratio
-0.520.240.180.09-0.26
EV/FCF Ratio
-0.530.260.220.40-0.26
Debt / EBITDA Ratio
-----0.00
Debt / FCF Ratio
-----0.00
Net Debt / Equity Ratio
-1.17-1.17-1.18-1.27-1.12-1.07
Net Debt / EBITDA Ratio
1.111.111.601.400.251.42
Net Debt / FCF Ratio
1.131.131.681.761.151.40
Asset Turnover
0.010.010.060.0200
Quick Ratio
5.285.286.804.938.997.25
Current Ratio
5.635.637.015.149.427.73
Return on Equity (ROE)
-74.58%-74.58%-66.65%-63.19%-294.69%-58.51%
Return on Assets (ROA)
-66.31%-66.31%-61.42%-58.60%-260.73%-50.05%
Return on Invested Capital (ROIC)
722.83%722.83%567.72%666.15%4352.43%510.66%
Return on Capital Employed (ROCE)
-78.34%-78.34%-73.65%-68.43%-296.60%-58.98%
Earnings Yield
-130.47%-226.26%-71.43%-84.04%-1027.04%-60.77%
FCF Yield
-133.53%-184.52%-75.26%-69.87%-142.58%-60.07%
Buyback Yield / Dilution
-18.67%-18.67%-52.31%-118.31%-55.69%-0.72%
Total Shareholder Return
-18.67%-18.67%-52.31%-118.31%-55.69%-0.72%
Updated Mar 16, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q